Open Label Clinical Trial of Vitamin D3 Dosage Tolerability, and Effect on Behavioral Measures in Children with Autism


Please note that this schedule is subject to change. The Program Book distributed at the Annual Meeting will have final information on dates, times, and speakers for each presentation.

New Research Poster Presentation 6.35
Open Label Clinical Trial of Vitamin D3 Dosage Tolerability, and Effect on Behavioral Measures in Children with Autism

Saturday, October 22, 2011

Faith P. Rohlke, B.A., Department of Psychiatry, University of California, San Francisco, San Francisco, CA

Robert L. Hendren, D.O., Department of Psychiatry, University of California, San Francisco, San Francisco, CA